DAVA Oncology’s 13th Whistler Summit on Hematologic Malignancies is a five-day meeting comprising presentations by leading experts in the field of hematologic malignancies, offering further insight into the always-evolving challenges encountered in clinical management.
The Whistler Summit aims to bridge conversation and collaboration between industry and academia. Supporting industry representatives will have an opportunity to showcase their data on emerging therapies that are being developed in the hematology space in addition to engaging faculty experts through various ancillary opportunities.
Chronic Lymphocytic Leukemia, Multiple Myeloma, Lymphoma, Acute Leukemias,
Myelodysplastic Syndrome, Myeloproliferative Neoplasms
DAVA Oncology
PMB Box # 108, 5930 Royal Ln, Ste E, Dallas, TX 75230